Accuracy of RESOLVE score derived from coronary computed tomography versus visual angiography to predict side branch occlusion in percutaneous bifurcation intervention.


Journal

Journal of cardiovascular computed tomography
ISSN: 1876-861X
Titre abrégé: J Cardiovasc Comput Tomogr
Pays: United States
ID NLM: 101308347

Informations de publication

Date de publication:
Historique:
received: 31 07 2019
revised: 29 09 2019
accepted: 20 11 2019
pubmed: 7 12 2019
medline: 8 9 2020
entrez: 7 12 2019
Statut: ppublish

Résumé

Visually estimated angiographic V-RESOLVE score was developed as a simple and accurate prediction tool for side branch (SB) occlusion in patients undergoing coronary bifurcation intervention. Data on the use of coronary computed tomography angiography (coronary CTA) for guiding percutaneous coronary intervention in bifurcation lesions is scarce. We aimed to validate the ability of quantitative CTA-derived RESOLVE score for predicting SB occlusion in coronary bifurcation intervention and to compare its predictive value with that of the angiography-based V-RESOLVE score. We included 363 patients with 400 bifurcation lesions. Angiographic V-RESOLVE score and CTA-derived RESOLVE score were calculated utilizing the weights from the QCA-based RESOLVE score. The scoring systems were divided into quartiles, and classified as the non-high-risk group and the high-risk group. Accuracy was assessed using areas under the receiver-operator characteristic curve (AUC). SB occlusion was defined as any decrease in Thrombolysis in Myocardial Infarction flow grade (including the absence of flow) in the SB after main vessel stenting. In total, 28 SB occlusions (7%) occurred. CTA-derived RESOLVE and V-RESOLVE scores achieved comparable predictive accuracy (0.709 vs. 0.752, respectively, p = 0.531) for predicting SB occlusion, and the analysis of AUC for each constituent element of the scores did not show any significant difference between CTA and visual angiography. The total net reclassification index was -18.6% (p = 0.194), and there were no significant differences in the rates of SB occlusion in the non-high-risk group (4.9% vs. 3.8%, p = 0.510) and the high-risk group (13.8% vs. 18.6%, p = 0.384) between CTA-derived RESOLVE and V-RESOLVE scores. The quantitative CTA-derived RESOLVE score is an accurate and reliable alternative to the visually estimated angiographic V-RESOLVE score for prediction of SB occlusion in coronary bifurcation intervention. URL: https://www.clinicaltrials.gov. Unique identifier: NCT03709836.

Identifiants

pubmed: 31806391
pii: S1934-5925(19)30437-X
doi: 10.1016/j.jcct.2019.11.007
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03709836']

Types de publication

Comparative Study Journal Article Observational Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

258-265

Informations de copyright

Copyright © 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Authors have no conflict of interest to declare.

Auteurs

Maksymilian P Opolski (MP)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland. Electronic address: mopolski@ikard.pl.

Kajetan Grodecki (K)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland; Medical University of Warsaw, Warsaw, Poland.

Adam D Staruch (AD)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.

Anna M Michalowska (AM)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland; Medical University of Warsaw, Warsaw, Poland.

Cezary Kepka (C)

Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland.

Rafal Wolny (R)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.

Paul Knaapen (P)

Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Stefan P Schumacher (SP)

Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Jerzy Pregowski (J)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.

Mariusz Kruk (M)

Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland.

Mariusz Debski (M)

Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland.

Artur Debski (A)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.

Ilona Michalowska (I)

Department of Radiology, Institute of Cardiology, Warsaw, Poland.

Adam Witkowski (A)

Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH